New bone marrow transplant unit for children with blood disorders opens in Ahmedabad
Sankalp India Foundation, in partnership with medical experts and donors, launches a 10-bed BMT unit to provide life-saving care for children with sickle cell disease and thalassemia
Sankalp India Foundation has announced the opening of a new 10-bed Bone Marrow Transplant (BMT) unit for children with blood disorders, including sickle cell disease and thalassemia, in Ahmedabad, Gujarat. The unit, located at Health 1 Super Speciality Hospital, has been established in collaboration with medical experts and donors to provide critical care for children requiring stem cell transplants.
The Sankalp-Health1 Centre for Paediatric Haematology, Oncology, and BMT is the first facility of its kind in the region. It is equipped with the latest medical technology to treat life-threatening blood disorders. The unit operates paperlessly to streamline patient care and improve efficiency, allowing families to access treatment without travelling long distances.
The inauguration ceremony was attended by Dr. Elke Neujahr, Global CEO of DKMS, and Mr. Shailesh Bhandari, Chairman of Electrotherm India Ltd. The unit has been dedicated to the memory of Mechtild Harf from DKMS.
Rajat Agarwal, President of Sankalp India Foundation, stated, “The opening of this BMT unit is a transformative moment for families affected by blood disorders in Gujarat and beyond. Our commitment to providing the best care possible for every child remains strong. This unit will serve as a beacon of hope for families in need of advanced treatment options.”
The initiative has been supported by Cure2Children Foundation, DKMS, Shree Jalaram Abhyudaya Sadbhavna Trust, and Electrotherm India. The unit is staffed with medical professionals and equipped with advanced facilities to ensure that children receive high-quality care and comprehensive support throughout their treatment.
- Advertisement -